1. Home
  2. RCKT vs XRX Comparison

RCKT vs XRX Comparison

Compare RCKT & XRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • XRX
  • Stock Information
  • Founded
  • RCKT 1999
  • XRX 1906
  • Country
  • RCKT United States
  • XRX United States
  • Employees
  • RCKT N/A
  • XRX N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • XRX Computer peripheral equipment
  • Sector
  • RCKT Health Care
  • XRX Technology
  • Exchange
  • RCKT Nasdaq
  • XRX Nasdaq
  • Market Cap
  • RCKT 1.4B
  • XRX 1.3B
  • IPO Year
  • RCKT N/A
  • XRX N/A
  • Fundamental
  • Price
  • RCKT $13.98
  • XRX $8.43
  • Analyst Decision
  • RCKT Strong Buy
  • XRX Sell
  • Analyst Count
  • RCKT 9
  • XRX 4
  • Target Price
  • RCKT $53.22
  • XRX $9.50
  • AVG Volume (30 Days)
  • RCKT 744.0K
  • XRX 3.0M
  • Earning Date
  • RCKT 11-07-2024
  • XRX 10-29-2024
  • Dividend Yield
  • RCKT N/A
  • XRX 11.86%
  • EPS Growth
  • RCKT N/A
  • XRX N/A
  • EPS
  • RCKT N/A
  • XRX N/A
  • Revenue
  • RCKT N/A
  • XRX $6,373,000,000.00
  • Revenue This Year
  • RCKT N/A
  • XRX N/A
  • Revenue Next Year
  • RCKT $411.05
  • XRX $2.82
  • P/E Ratio
  • RCKT N/A
  • XRX N/A
  • Revenue Growth
  • RCKT N/A
  • XRX N/A
  • 52 Week Low
  • RCKT $13.80
  • XRX $8.02
  • 52 Week High
  • RCKT $32.53
  • XRX $19.78
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 27.71
  • XRX 37.46
  • Support Level
  • RCKT $16.65
  • XRX $8.20
  • Resistance Level
  • RCKT $17.83
  • XRX $9.17
  • Average True Range (ATR)
  • RCKT 0.89
  • XRX 0.41
  • MACD
  • RCKT -0.27
  • XRX -0.01
  • Stochastic Oscillator
  • RCKT 4.12
  • XRX 35.65

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About XRX Xerox Holdings Corporation

Xerox is an original equipment manufacturing and software company. Xerox operates in one segment--design, development, and sale of printing technology and related solutions--while deriving 60% of its revenue from the U.S. and 40% from international markets. The company is an OEM of multifunction printers, or MFPs (printers that can print, copy, and scan), focusing on large enterprise markets. Apart from equipment, the company provides post-sales services like managed print services--a service that helps to bring smart servicing and efficiencies to how employers use their print/copy equipment. Xerox is attempting to enter new markets like digital print packaging solutions and printed electronics.

Share on Social Networks: